MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nanoff, C.
Right arrow Articles by Stiles, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nanoff, C.
Right arrow Articles by Stiles, G. L.

The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis

C Nanoff, KA Jacobson and GL Stiles

Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Agonist binding to the A2 adenosine receptor (A2AR) and its regulation by guanine nucleotides was studied using the newly developed radioligand 125I-2-[4-(2-[2-[(4-aminophenyl)methylcarbonylamino] ethylaminnocarbonyl]ethyl)phenyl]ethylamino-5'-N- ethylcarboxamidoadenosine (125I-PAPA-APEC) and its photoaffinity analog 125I-azido-PAPA-APEC. A single protein of Mr 45,000, displaying the appropriate A2AR pharmacology, is labeled in membranes from bovine striatum, PC12 cells, and frog erythrocytes. In DDT1 MF2 cells the labeled protein has a slightly lower molecular weight. Incorporation of 125I-azido-PAPA-APEC into membranes from rabbit striatum, however, reveals two specifically labeled peptides (Mr approximately 47,000 and 38,000), both of which display A2AR pharmacology. Inhibition of protease activity leads to a decrease in the amount of the Mr 38,000 protein, with only the Mr 47,000 protein remaining. This suggests that the Mr 38,000 peptide is a proteolytic product of the Mr 47,000 A2AR protein. In membranes containing the intact undigested A2AR protein, guanine nucleotides induce a small to insignificant decrease in agonist binding, which is atypical of stimulatory GS-coupled receptors. This minimal effect is observed in rabbit striatal membranes prepared in the presence of protease inhibitors, as well as in the other tissues studied. Binding to rabbit striatal membranes that possess the partially digested receptor protein, however, reveals a 50% reduction in maximal specific agonist binding upon addition of guanine nucleotides. Inhibition of proteolysis in rabbit striatum, on the other hand, results in a diminished ability of guanine nucleotides to regulate agonist binding. Thus, the enhanced effectiveness of guanine nucleotides in rabbit striatal membranes is associated with the generation of the Mr 38,000 peptide fragment. Guanosine 5'-(beta,gamma- imido)triphosphate reduces photoaffinity labeling by 55% in the Mr 38,000 protein, whereas the labeling is decreased by only 28% in the Mr 47,000 receptor protein. Our data, therefore, suggest that, unless proteolysis occurs, the A2AR in all tissues studied is tightly associated with the GS protein and displays minimal guanine nucleotide modulation of agonist binding, which makes the A2AR an atypical stimulatory receptor.

Volume 39, Issue 2, pp. 130-135, 02/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Charalambous, I. Gsandtner, S. Keuerleber, L. Milan-Lobo, O. Kudlacek, M. Freissmuth, and J. Zezula
Restricted Collision Coupling of the A2A Receptor Revisited: EVIDENCE FOR PHYSICAL SEPARATION OF TWO SIGNALING CASCADES
J. Biol. Chem., April 4, 2008; 283(14): 9276 - 9288.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Yang, V. R. Tuniki, S. Anjaiah, J. R. Falck, C. J. Hillard, and W. B. Campbell
Characterization of Epoxyeicosatrienoic Acid Binding Site in U937 Membranes Using a Novel Radiolabeled Agonist, 20-125I-14,15-Epoxyeicosa-8(Z)-Enoic Acid
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1019 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Yu, L. C. Zacharia, E. K. Jackson, and G. Apodaca
Adenosine receptor expression and function in bladder uroepithelium
Am J Physiol Cell Physiol, August 1, 2006; 291(2): C254 - C265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Gsandtner, C. Charalambous, E. Stefan, E. Ogris, M. Freissmuth, and J. Zezula
Heterotrimeric G Protein-independent Signaling of a G Protein-coupled Receptor: DIRECT BINDING OF ARNO/CYTOHESIN-2 TO THE CARBOXYL TERMINUS OF THE A2A ADENOSINE RECEPTOR IS NECESSARY FOR SUSTAINED ACTIVATION OF THE ERK/MAP KINASE PATHWAY
J. Biol. Chem., September 9, 2005; 280(36): 31898 - 31905.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. R. Mazzoni, S. Taddei, L. Giusti, P. Rovero, C. Galoppini, A. D'Ursi, S. Albrizio, A. Triolo, E. Novellino, G. Greco, et al.
A Galpha s Carboxyl-Terminal Peptide Prevents Gs Activation by the A2A Adenosine Receptor
Mol. Pharmacol., July 1, 2000; 58(1): 226 - 236.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
Z. Nie, Y. Mei, R. L. Malek, A. Marcuzzi, N. H. Lee, and V. Ramkumar
A Role of p75 in NGF-Mediated Down-Regulation of the A2A Adenosine Receptors in PC12 Cells
Mol. Pharmacol., November 1, 1999; 56(5): 947 - 954.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
F. Roka, L. Brydon, M. Waldhoer, A. D. Strosberg, M. Freissmuth, R. Jockers, and C. Nanoff
Tight Association of the Human Mel1a-Melatonin Receptor and Gi: Precoupling and Constitutive Activity
Mol. Pharmacol., November 1, 1999; 56(5): 1014 - 1024.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. G. Seidel, M. Klinger, M. Freissmuth, and C. Holler
Activation of Mitogen-activated Protein Kinase by the A2A-adenosine Receptor via a rap1-dependent and via a p21ras-dependent Pathway
J. Biol. Chem., September 3, 1999; 274(36): 25833 - 25841.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Florio, F. Frausin, R. Vertua, and R. M. Gaion
Amplification of the Cyclic AMP Response to Forskolin in Pheochromocytoma PC12 Cells through Adenosine A2A Purinoceptors
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 817 - 824.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. B. Marala and S. J. Mustafa
Immunological Characterization of Adenosine A2A Receptors in Human and Porcine Cardiovascular Tissues
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1051 - 1057.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
I. Feoktistov and I. Biaggioni
Adenosine A2B Receptors
Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Casavola, L. Guerra, S. J. Reshkin, K. A. Jacobson, and H. Murer
Polarization of Adenosine Effects on Intracellular pH in A6 Renal Epithelial Cells
Mol. Pharmacol., March 1, 1997; 51(3): 516 - 523.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Olah and M. E. Olah
Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS. ANALYSIS OF CHIMERIC A1/A2a ADENOSINE RECEPTORS
J. Biol. Chem., January 3, 1997; 272(1): 337 - 344.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. T. Liang and B. Haltiwanger
Adenosine A2a and A2b Receptors in Cultured Fetal Chick Heart Cells : High- and Low-Affinity Coupling to Stimulation of Myocyte Contractility and cAMP Accumulation
Circ. Res., February 1, 1995; 76(2): 242 - 251.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics